Peptide ligand-mediated targeted drug delivery of nanomedicines. (18th January 2019)

• Record Type: Journal Article
• Authors: Jiang, Zhuxuan; Guan, Juan; Qian, Jun; Zhan, Changyou
• Is Part Of: Biomaterials science. Volume 7:Number 2(2019)
• Page Start: 461
• Page End: 471
• Publication Date: 2019-01-18
• Subjects: Biomedical materials -- Periodicals; 610.28
• DOI: 10.1039/c8bm01340c
• Languages: English
• ISSNs: 2047-4830

Abstract

Abstract : Targeted drug delivery is emerging as a promising strategy to achieve better clinical outcomes. Abstract : Targeted drug delivery is emerging as a promising strategy to achieve better clinical outcomes. Actively targeted drug delivery that utilizes overexpressed receptors or antigens on diseased tissues is receiving increasing scrutiny, especially due to the uncertainty of existence of the enhanced permeability and retention (EPR) effect in cancer patients. Peptide ligands are advantageous over other classes of targeting ligands due to their accessibility of high-throughput screening, ease of synthesis, high specificity and affinity, etc. In this review, we briefly summarize the resources of peptide ligands and discuss the pitfalls and perspectives of peptide ligand-mediated targeted delivery of nanomedicines.